Webinar: Reimbursement Strategies for Stem Cell Therapy Products

Webinar Event:
"Reimbursement Strategies Webinar: Planning Your Payment Strategy in Early Regenerative Medicine Product Development"

Presented June 20, 2013

Click here to download the powerpoint slides from the presentation



  • Michael Werner, J.D., Executive Director, Alliance for Regenerative Medicine; Partner at Holland & Knight, LLP
  • Randy Fenninger, J.D., Principal, Creek Crossing Advisors


  • Primer on coding, coverage and payment rules and processes that determine whether a regenerative medicine product will be reimbursed
  • Understanding why you should develop and adopt a reimbursement strategy early in product development
  • Understand how your reimbursement strategy and regulatory strategy coincide
  • Understand how new reimbursement rules and payment models such as ACOs, payment bundling, and comparative effectiveness analysis will affect regenerative medicine technologies and develop strategies to succeed.
  • Questions and Answers

Disease Programs

Learn about how CIRM-funded stem cell research could generate treatments for many chronic diseases and injuries.

See disease fact sheets

CIRM Stem Cell Blog